Results 111 to 120 of about 58,007 (253)

Splenic Infarction After Sclerotherapy for Gastric Varices due to Anatomical Variation of Left Gastric Artery: A Case Report and Literature Review

open access: yes
Journal of Digestive Diseases, Volume 26, Issue 1-2, Page 88-91, January-February 2025.
Shuai Jie Qian   +4 more
wiley   +1 more source

The impact of immature granulocytes on the outcome of patients with decompensated cirrhosis

open access: yesEuropean Journal of Clinical Investigation, EarlyView.
Immature granulocyte (IG) count and percentage had a predictive role in patients with decompensated cirrhosis, making them an objective and easily available marker of prognosis for this group of patients. In addition, IG percentage was the only factor independently associated with transplant‐free survival.
Magdalini Adamantou   +10 more
wiley   +1 more source

Evaluation of diagnostic criteria for mild‐to‐advanced stages of Fontan‐associated liver disease: A nationwide epidemiological survey in Japan

open access: yesHepatology Research, Volume 55, Issue 4, Page 611-621, April 2025.
Fontan‐associated liver disease (FALD) is a frequent complication after Fontan surgery. Data from 1168 Fontan patients, including blood tests, imaging, and pathology, from high‐volume centers across Japan were used to develop diagnostic criteria for FALD and advanced FALD. The proposed diagnostic criteria accurately identified FALD in 86.8% of patients,
Tomomi Kogiso   +4 more
wiley   +1 more source

Pancreatic congestion is associated with exocrine pancreatic function in liver cirrhosis

open access: yesHepatology Research, Volume 55, Issue 5, Page 685-695, May 2025.
Abstract Aim Portal hypertension resulting from liver cirrhosis (LC) can lead to pancreatic congestion and impaired insulin secretion. Therefore, this prospective study aimed to assess the association between pancreatic congestion and exocrine pancreatic function in patients with LC.
Masahito Kokubu   +9 more
wiley   +1 more source

Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease

open access: yesJHEP Reports, 2023
Background & Aims: We aimed to evaluate the impact of oesophageal varices (OV) and their evolution on the risk of complications of compensated advanced chronic liver disease (cACLD) caused by non-alcoholic fatty liver disease (NAFLD).
Grazia Pennisi   +28 more
doaj  

Effectiveness and safety of antithrombin for treatment of portal vein thrombosis: Nationwide prospective surveillance of 4 years of clinical experience in Japan

open access: yesHepatology Research, EarlyView.
Abstract Aim Antithrombin (AT), a plasma protein with anticoagulant properties, has a long‐standing medical history, primarily for treatment of congenital AT deficiency. Accumulated clinical experiences suggest AT is a potential anticoagulant for thrombotic diseases. This study aimed to clarify the effectiveness, safety, and clinical significance of AT
Shoichi Matsutani   +2 more
wiley   +1 more source

Ectopic varices [PDF]

open access: yesClinical Liver Disease, 2012
Shiv Kumar Sarin, Chandan Kumar
openaire   +2 more sources

Validation of PBC‐10 in Japanese patients with primary biliary cholangitis

open access: yesHepatology Research, EarlyView.
This study validates the Japanese version of the PBC‐10, a short‐form health‐related quality of life (HRQOL) assessment tool for patients with primary biliary cholangitis (PBC). The findings confirm its reliability and strong correlation with the PBC‐40, supporting its use for rapid clinical screening of HRQOL impairments in Japanese patients. Abstract
Akihito Takeuchi   +18 more
wiley   +1 more source

Pathophysiology of Portal Hypertension and Esophageal Varices

open access: yesInternational Journal of Hepatology, 2012
Esophageal varices are the major complication of portal hypertension. It is detected in about 50% of cirrhosis patients, and approximately 5–15% of cirrhosis patients show newly formed varices or worsening of varices each year.
Hitoshi Maruyama, Osamu Yokosuka
doaj   +1 more source

Genetic analysis of the correlation between GLP1 action and metabolic liver disease: Insights from Mendelian randomization analysis

open access: yesJournal of Diabetes Investigation, EarlyView.
Our study provides genetic analysis supporting the beneficial effects of GLP1 action on MASLD. These benefits may be attributed to mechanisms such as lowering blood glucose levels, reducing blood pressure, and improving HDL cholesterol levels. ABSTRACT Purpose Previous studies have shown that glucagon‐like peptide 1 (GLP1) receptor agonists may help ...
Zhiqiang Ma   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy